Veracyte, Inc.
NASDAQ:VCYT · NASDAQ Global Market
+$1.83 today
Vol 3.04M · Avg 1.05M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+100.79%
Period High
$53.63
Period Low
$23.03
Latest
$53.63
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Scholar Rock Holding Corporation
NASDAQ:SRRK
$5.60B
Legend Biotech Corporation
NASDAQ:LEGN
$5.45B
Apellis Pharmaceuticals, Inc.
APLS
$5.25B
Amicus Therapeutics, Inc.
FOLD
$4.55B
Kiniksa Pharmaceuticals, Ltd.
NASDAQ:KNSA
$4.10B
IDEAYA Biosciences, Inc.
NASDAQ:IDYA
$2.96B
Adaptive Biotechnologies Corporation
NASDAQ:ADPT
$2.79B
Tarsus Pharmaceuticals, Inc.
NASDAQ:TARS
$2.71B
Disc Medicine, Inc.
NASDAQ:IRON
$2.70B
Zai Lab Limited
NASDAQ:ZLAB
$2.08B
What is the latest VCYT filing?
The latest filing shown is 4 dated Jun 15, 2026.
How many recent filings does VCYT have?
Intrinsic Alpha currently shows 20 recent filings for VCYT.
Explore More
Continue the stock analysis
Jump to another research area for this company.